suritozole has been researched along with triazoles in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kane, JM; Moran, PM; Moser, PC | 1 |
Dudley, MW; Kane, JM; Kehne, JH; Miller, JA; Sorensen, SM | 1 |
Dudchenko, P; Holley, LA; Sarter, M | 1 |
Kane, JM; Sorensen, SM; Zwolshen, JM | 1 |
Hamm, RJ; O'Dell, DM | 1 |
Chmielewski, PA; Dudchenko, P; Holley, LA; Miller, JA; Sarter, M | 1 |
Bhargava, VO; Green, VI; Hutcheson, SJ; Miller, TD; Robbins, DK; Weir, SJ | 1 |
1 trial(s) available for suritozole and triazoles
Article | Year |
---|---|
Pharmacokinetics of MDL 26479, a novel benzodiazepine inverse agonist, in normal volunteers.
Topics: Administration, Oral; Adult; Antidepressive Agents; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; Humans; Male; Middle Aged; Reference Values; Triazoles | 1997 |
6 other study(ies) available for suritozole and triazoles
Article | Year |
---|---|
Enhancement of working memory performance in the rat by MDL 26,479, a novel compound with activity at the GABAA receptor complex.
Topics: Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Learning; Male; Memory; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reference Values; Reinforcement, Psychology; Scopolamine; Triazoles | 1992 |
MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties.
Topics: Animals; Behavior, Animal; Benzodiazepines; Binding Sites; Carbolines; Cognition; Convulsants; Diazepam; Flumazenil; Hemicholinium 3; Hippocampus; In Vitro Techniques; Male; Mice; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazoles | 1992 |
Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alternation performance by the triazole MDL 26,479.
Topics: Animals; Antidepressive Agents; Cognition; Dose-Response Relationship, Drug; Male; Memory, Short-Term; Muscarinic Antagonists; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Scopolamine; Triazoles | 1992 |
The effects of a potential antidepressant, 2,4-dimethyl-5-(3-fluorophenyl)-3H-1,2,4-triazole-3-thione, in an electrophysiological model responsive to desipramine.
Topics: Action Potentials; Animals; Antidepressive Agents; Desipramine; Electrophysiology; gamma-Aminobutyric Acid; Male; Models, Biological; Norepinephrine; Purkinje Fibers; Rats; Rats, Inbred Strains; Triazoles | 1990 |
Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury.
Topics: Animals; Brain Injuries; Drug Administration Schedule; Male; Memory; Memory Disorders; Parasympathetic Nervous System; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Space Perception; Time Factors; Triazoles | 1995 |
Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission.
Topics: Animals; Antidepressive Agents; Autoradiography; Biomarkers; Body Weight; Choline O-Acetyltransferase; Conditioning, Operant; Hemicholinium 3; Ibotenic Acid; Immunohistochemistry; Learning; Neuromuscular Depolarizing Agents; Parasympathetic Nervous System; Piperidines; Prosencephalon; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Synaptic Transmission; Triazoles | 1993 |